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Activation of Transient Receptor Potential Vanilloid-3
Inhibits Human Hair Growth
Istva´n Borbı´ro´1,2, Erika Lisztes1,2, Bala´zs I. To´th1, Gabriella Czifra1, Attila Ola´h1, Attila G. Szo¨ll +osi1,
Norbert Szentandra´ssy1, Pe´ter P. Na´na´si1, Zolta´n Pe´ter3, Ralf Paus4, La´szlo´ Kova´cs1 and Tama´s Bı´ro´1,2
In the current study, we aimed at identifying the functional role of transient receptor potential vanilloid-3
(TRPV3) ion channel in the regulation of human hair growth. Using human organ-cultured hair follicles (HFs)
and cultures of human outer root sheath (ORS) keratinocytes, we provide the first evidence that activation of
TRPV3 inhibits human hair growth. TRPV3 immunoreactivity was confined to epithelial compartments of the
human HF, mainly to the ORS. In organ culture, TRPV3 activation by plant-derived (e.g., eugenol, 10–1,000 mM) or
synthetic (e.g., 2-aminoethoxydiphenyl borate, 1–300 mM) agonists resulted in a dose-dependent inhibition of
hair shaft elongation, suppression of proliferation, and induction of apoptosis and premature HF regression
(catagen). Human ORS keratinocytes also expressed functional TRPV3, whose stimulation induced membrane
currents, elevated intracellular calcium concentration, inhibited proliferation, and induced apoptosis. Of great
importance, these effects on ORS keratinocytes were all mediated by TRPV3, as small interfering RNA-mediated
silencing of TRPV3 effectively abrogated the cellular actions of the above agonists. These findings collectively
support the concept that TRPV3 signaling is a significant player in human hair growth control. Therefore, TRPV3
and the related intracellular signaling mechanism might function as a promising target for pharmacological
manipulations of clinically relevant hair growth disorders.
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INTRODUCTION
Members of the large transient receptor potential (TRP) ion
channel family function as ‘‘polymodal cellular temperature
sensor’’ molecules. Indeed, these channels were shown to be
involved in sensation of, e.g., temperature challenges,
chemical irritants, osmolarity, taste, pain, itch, and so on
(Sza´lla´si and Blumberg, 1999; Caterina and Julius, 2001;
Clapham, 2003; Paus et al., 2006a; Bı´ro´ et al., 2007; Nilius
et al., 2007).
Emerging results of the past decade, however, have
suggested that roles of TRP channels are, by no means,
restricted to sensory neuron-coupled processes. Stimulated
not the least by our pioneering studies with TRPV1
(the ‘‘capsaicin receptor’’ of the vanilloid subgroup) on glial
and mast cells (Bı´ro´ et al., 1998a, b), it has now become clear
that functional TRP channels are also expressed on many
different non-neuronal cell types. In the skin, TRPV1 was
identified on human epidermal and hair follicle (HF)
keratinocytes, sebocytes, mast cells, and dendritic cells
(Denda et al., 2001; Southall et al., 2003; Bodo´ et al.,
2004). We have also shown that TRPV1 activation suppressed
in vitro human hair growth, inhibited proliferation of
epidermal keratinocytes and sebocytes, induced apoptosis
of skin cells, and inhibited lipid synthesis of sebocytes
(Bodo´ et al., 2005; To´th et al., 2009b). Finally, we have
detected a significant delay in HF cycling of TRPV1 knock
out mice compared with the wild-type control (Bı´ro´ et al.,
2006). These findings have introduced TRPV1 as a significant
player in human (and murine) skin and hair growth
control, and suggested that TRP channels and their
endogenous ligands may represent additional players in
the neuroendocrine network of the skin (Slominski and
Wortsman, 2000).
Intriguingly, another thermosensitive TRP channel, i.e.,
transient receptor potential vanilloid-3 (TRPV3), which is
abundantly expressed in murine keratinocytes (Peier et al.,
2002; Smith et al., 2002; Xu et al., 2002; Moussaieff et al.,
2008), was recently also implicated in the regulation of
murine epidermal and hair growth. It was also shown that a
constitutively active, ‘‘gain-of-function’’ mutation of the trpv3
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gene resulted in a hairless phenotype in mice (and rats;
Asakawa et al., 2006; Xiao et al., 2008). Finally, an elegant
study (Cheng et al., 2010) has recently demonstrated that
TRPV3-coupled signaling mechanisms are key regulators of
epidermal growth factor-induced murine hair morphogenesis
and skin barrier formation.
Although these interesting data strongly suggested that
TRPV3 (similar to TRPV1) may have a profound regulatory
role in murine hair growth (Steinhoff and Bı´ro´, 2009);
moreover, although expression of TRPV3 was identified in
the human skin in situ (Xu et al., 2002; Gopinath et al., 2005;
Facer et al., 2007), we lack data on its function in human hair
growth control. Therefore, in the current study, we aim at
defining whether TRPV3-coupled signaling is involved in the
regulation of human hair growth and cycling. Specifically, we
intended to identify the expression of TRPV3 in human organ-
cultured HFs and in primary cultures of HF-derived outer root
sheath (ORS) keratinocytes using immunolabeling and
quantitative ‘‘real-time’’ PCR. Furthermore, using a wide-
array of functional assays and molecular imaging, we have
evaluated the effects of plant-derived and synthetic TRPV3
activators on hair shaft elongation, intrafollicular and ORS
keratinocyte proliferation and apoptosis, HF cycling, intra-
cellular ionic homeostasis, and channel activity. Finally, we
have analyzed the TRPV3 specificity of the observed cellular
actions of the TRPV3 agonists using RNA interference (RNAi).
Collectively, our study provides the first evidence that
activation of TRPV3 inhibits human hair growth, and the
findings strongly support the possibility that TRPV3 and the
related intracellular signaling mechanism might function
as a promising target for pharmacological manipulations of
clinically relevant hair growth disorders.
RESULTS
Human scalp HF express TRPV3 mainly in the ORS
First, we intended to define TRPV3 expression in the human
HF in vivo, using full-thickness normal scalp skin obtained
during routine plastic surgery. As revealed by immunohis-
tochemistry, TRPV3-immunoreactivity (IR) in human scalp
HF in anagen VI stage of the hair cycle (Paus and Cotsarelis,
1999; Stenn and Paus, 2001) was restricted mostly to the
keratinocyte layers of the ORS and, to lesser extent, to
the matrix of the HF (Figure 1a). In good accord with
these data, a strong TRPV3-IR was observed on cultured
ORS keratinocytes, both by immunocytochemistry (Figure 1b)
and Western blotting (Figure 1c). The specificity of the
immunosignal was assessed by numerous positive and
negative controls (see also Materials and Methods section
for details).
To control whether intraepithelial TRPV3-IR corresponded
to the presence of TRPV3 transcripts, RNA was rapidly
extracted from freshly microdissected proximal human
anagen HFs and from ORS keratinocyte cultures and then
samples were subjected to quantitative real-time PCR. As
shown in Figure 1d, mRNA transcripts for TRPV3 were
unambiguously identified both in normal human scalp HF
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Figure 1. Transient receptor potential vanilloid-3 (TRPV3) is expressed in the epithelium of human hair follicle (HF) and on cultured outer root sheath
(ORS) keratinocytes. Immunofluorescence (green) of TRPV3 in organ-cultured human HFs in situ (a) and on primary cultures of ORS keratinocytes (b). DP,
dermal papilla; MK, matrix keratinocytes. Bars¼50 mm (a) and 10 mm (b). ORS keratinocytes were identified by cytokeratin 7 (CK7) immunolabeling (red
fluorescence). Nuclei were counterstained with 40-6-diamidino-2-phenylindole (DAPI, blue fluorescence). Insets: pre-absorption negative control (NC). (c)
TRPV3 protein expression in human ORS and epidermal HaCaT keratinocytes, as determined by western blotting. (d) TRPV3 mRNA expression in human anagen
and catagen HFs, ORS keratinocytes (ORSK), DP fibroblasts (DPF), and dermal fibroblasts (HDF), as assessed by quantitative real-time PCR. Data are
expressed as mean±SEM of three independent determinations performed in triplicate.
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and in HF-derived ORS keratinocytes suggesting that the
human HF epithelium indeed transcribes the TRPV3 gene
in vivo.
In these experiments, two other important findings have
been revealed. First, TRPV3-IR (Figure 1a) and specific mRNA
transcripts (Figure 1d) were absent from the inductive,
specialized HF mesenchyme, the fibroblasts of the dermal
papilla as well as from human dermal fibroblast (HDF; Figure
1d) used as feeder layers for the ORS keratinocyte cultures.
Second, expression of TRPV3 in the ORS and matrix
keratinocyte layers of the human HF appeared to be not
regulated by the cycling machinery of the HF, as the levels of
TRPV3-specific mRNA transcripts (Figure 1d) and IR (data not
show) were essentially the same in anagen and in sponta-
neously transformed catagen HFs.
TRPV3 stimulation inhibits hair shaft elongation and hair matrix
keratinocyte proliferation, and induces apoptosis-driven
premature catagen regression
To explore the functional consequences of TRPV3 stimulation
in vitro under as physiological conditions as possible,
microdissected, organ-cultured normal anagen VI scalp HF
were exposed to various TRPV3 agonists (Chung et al.,
2004a; Xu et al., 2006). Plant-derived agents, such as eugenol
(Figure 2), thymol, and carvacrol (data not shown)—major
components of clove, thyme, and oregano—and the synthetic
agonist 2-aminoethoxydiphenyl borate (2-APB) significantly
inhibited hair shaft elongation in a time- and dose-dependent
manner (Figure 2a).
Hair growth inhibition was further confirmed by the
finding that treatment of cultured HFs by these activators for
5 days significantly decreased the number of Ki67þ
keratinocytes in the anagen hair bulb (Figure 2b). Of further
importance, the above agents significantly increased the
number of TUNELþ keratinocytes in the hair bulb after
stimulation, suggesting the induction of apoptosis by TRPV3
stimulation (Figure 2b).
Using quantitative histomorphometry of HE-staining
section of HF and analyzing such staining based on well-
defined morphological criteria (Mu¨ller-Ro¨ver et al., 2001;
Stenn and Paus, 2001), we next assessed the effect of the
TRPV3 agonists on HF cycling in vitro, namely on the
anagen–catagen transition, which is characterized by massive
upregulation of keratinocyte apoptosis and downregulation of
keratinocyte proliferation in the anagen hair bulb (Lindner
et al., 1997; Mu¨ller-Ro¨ver et al., 2001; Stenn and Paus,
2001). As shown in Figure 2c, the agonists stimulated the
onset of catagen transformation of the HF, whereas in
the control, most of the HFs (480 %) were in the anagen
VI phase, after 8 days of treatment with eugenol or 2-APB,
60–100% of the HF had entered catagen (Figure 2c). It should
be noted, however, that these TRPV3 agonists were largely
capable of inducing only early catagen stages, and that we
very rarely found that HF regression in vitro had progressed
into late stages of the catagen transformation after application
of these agents.
TRPV3 is expressed as a Ca2þ -permeable ion channel on ORS
keratinocytes
Although the above data argued for the functional expression
of TRPV3 in keratinocyte layers of the human HF, to further
analyze the functionality of the TRPV3 channel, a series
dynamic imaging and electrophysiology experiments were
performed on primary cultures of human ORS keratinocytes,
which, as we have shown above (Figure 1), express TRPV3-
specific mRNA transcripts and proteins.
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Figure 2. In organ-cultured hair follicles (HFs), stimulation of transient receptor potential vanilloid-3 (TRPV3) inhibits human hair shaft elongation and
intrafollicular proliferation, and induces apoptosis and premature catagen regression. (a) Hair shaft elongation curves (18–24 HFs per group, mean±SEM).
*Po0.05 when compared with control. (b) Co-immunolabeling of proliferating (Ki-67þ , red fluorescence) and apoptotic (TUNELþ , green fluorescence) cells,
along with nuclei (40-6-diamidino-2-phenylindoleþ , DAPI, blue fluorescence). Statistical analysis of number of Ki-67þ and TUNELþ cells as compared with
the number of DAPIþ cells. (c) Quantitative hair cycle histomorphometry on hematoxylin–eosin-stained sections. Percentage of HF in anagen or catagen state
was determined. (b,c) Data are expressed as mean±SEM. *Po0.05 when compared with control. DP, dermal papilla; MK, matrix keratinocytes; 2-APB,
2-aminoethoxydiphenyl borate. Bars¼50 mm.
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As revealed by FLIPR-based Ca2þ -imaging (Marincsa´k
et al., 2008; To´th et al., 2009b), TRPV3 agonists markedly
increased [Ca2þ ]ic in a dose-dependent manner (Figure 3a
and b). Of further importance, suppression of [Ca2þ ] of the
culturing medium (from 1.8 to 0.02 mM) or co-application of
10 mM ruthenium red (a nonselective channel blocker; Amann
and Maggi, 1991) almost fully prevented the actions of the
TRPV3 agonists to elevate [Ca2þ ]ic (Figure 3b), suggesting
that these agents opened a Ca2þ -permeable conductance at
the surface membrane of the ORS keratinocytes.
To further assess this phenomenon, patch-clamp (whole-
cell configuration) experiments were performed. As mem-
brane currents elicited by square pulses activated quickly and
showed no time- and voltage-dependent inactivation (data
not shown), currents were initiated by ramp protocols (Figure
3c), applied in every 3 seconds. Control (i.e., vehicle-treated)
ORS keratinocytes showed outwardly rectifying currents with
an average reversal potential of 12.6±1.5 mV (mean±
SEM, n¼7). Currents were measured and normalized to cell
membrane capacitance at four different potential during the
ramp protocol, i.e., at 90, 40, þ40, and þ 90 mV resul-
ting 9.5±2.5, 3.5±1.0, 6.2±1.0, and 15.9±3.5 pA/pF,
respectively (all data are mean±SEM values) (Figure 3e).
Of great importance, both inward and outward currents
were markedly and significantly (Po0.05) increased
by 100mM 2-APB (Figure 3c–f), which effect was reversible.
2-APB normal Ca2+
2-APB low Ca2+
400
300
200
100
0
0 2
Time (minutes)
Time (minutes)
100 µM 2-APB
Washout
*
*
100 mV
3
3
@ +90 mV
@ ±40 mV @ ±90 mV @ –40 mV @ +90 mV
@ –40 mV
100 µM 2-APB
2
1
0
–1
500
400
300
200
100
0 2 4 6
2
1
–1
75 Control *
100 µM 2-APB
Washout50
25
0
–25
–50
–100 –50
50 100
Voltage (mV)
200 ms–40 mV
–100 mV
Control
Washout
Cu
rre
nt
 (n
A)
Cu
rre
nt
 (n
A)
Cu
rre
nt
 (p
A/
pF
)
100 µM 2-APB
64
R
el
at
ive
 fl
uo
re
sc
en
ce
in
 %
 o
f b
as
el
in
e
400
Normal Ca2+
Low Ca2+
Ruthenium red
*
*
##
# #
*
*
# #
# #
300
200
100
0
Control 100 300 1,000300
R
el
at
ive
 fl
uo
re
sc
en
ce
in
 %
 o
f b
as
el
in
e
N
or
m
a
liz
e
d 
cu
rre
nt
(%
 of
 co
ntr
ol)
Eugenol normal Ca2+
Eugenol low Ca2+
Eugenol (µM)2-APB (µM)
Figure 3. Transient receptor potential vanilloid-3 (TRPV3) is expressed as a Ca2þ -permeable ion channel on human outer root sheath (ORS) keratinocytes.
(a) Representative fluorimetric Ca2þ -imaging data recorded on Fluo-4-loaded ORS keratinocytes. The arrow indicates the application of 100mM
2-aminoethoxydiphenyl borate (2-APB) and 300mM eugenol in solutions containing normal (1.8 mM) or low (0.02mM) [Ca2þ ]. (b) Statistical analysis of
maximal amplitudes of Ca2þ -elevations induced by the TRPV3 agonists in normal (1.8 mM) or low (0.02mM) [Ca2þ ] solutions, or in the presence of 10mM ruthenium
red (measured in normal [Ca2þ ] solution). In all cases, mean±SEM of multiple determinations (n43) is presented. For statistical analysis, * marks significant
(Po0.05) differences compared with the control, whereas # marks significant (Po0.05) differences compared with the maximal TRPV3 activator-induced
Ca2þ -elevations recorded in normal [Ca2þ ] solution. (c) Representative I–V curves recorded with a patch-clamp ramp protocol shown in the inset. (d) A usual time
course of a single experiment showing 100mM 2-APB-induced current values measured at 40mV (open symbols) and at þ90 mV (filled symbols). (e) Statistical
analysis of normalized currents to cell membrane capacitance (mean±SEM, n¼7) measured at 40mV (left side downward), þ 40mV (left side upward), 90mV
(right side downward), and þ 90mV (right side upward) in different conditions. (f) Statistical analysis of normalized currents in the presence and after washout
of 100mM 2-APB measured at 40mV (left) and þ 90mV (right; mean±SEM, n¼ 7). (e,f) * Marks significant (Po0.05) differences compared with the control.
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In the presence of 2-APB, the currents measured at 90, 40,
þ 40, and þ90 mV were –31.9±14.2, 13.8±6.4, 17.3±
6.1, and 57.7±16.6 pA/pF, respectively (mean±SEM, n¼ 7).
In average, the TRPV3 activator approximately tripled both
inward and outward currents at all potentials. (Notably, all
other plant-derived TRPV3 activator exerted similar effects
(data not shown)). We have also shown that 10 mM ruthenium
red markedly (by 62%, measured at þ 90 mV, n¼3)
suppressed the amplitude of the 2-APB-induced current (data
not shown).
Collectively, these data unambiguously argue for the fact
that human HF-derived ORS keratinocytes indeed express
functional TRPV3, which operates as a Ca2þ -permeable
(most probably nonselective cation) channel at the plasma
membrane of the cells, similar to that previously described
for various epidermal keratinocyte populations (Peier et al.,
2002; Chung et al., 2004a, 2004b; Huang et al., 2008;
Cheng et al., 2010).
TRPV3 stimulation suppresses proliferation of ORS
keratinocytes and induces cell death
As TRPV3 stimulation of organ-cultured HFs inhibited hair
shaft elongation and intrafollicular proliferation, and induced
apoptosis (Figure 2), we next investigated the cellular effects
of TRPV3 activation on growth and survival of human ORS
keratinocytes. In good accord with these data, as revealed by
a wide-array of FLIPR-based functional assays, eugenol and
2-APB suppressed cellular growth of ORS keratinocytes in a
dose-dependent manner (Figure 4a–c). In addition, the TRPV3
activators markedly suppressed the mitochondrial membrane
potential (Figure 4a–c), one of the earliest hallmarks of
apoptosis (Green and Reed, 1998; Susin et al., 1998). Finally,
highest concentrations of the agents were also able to
significantly (Po0.05) increase Sytox Green accumulation
(Figure 4a), a sensitive indicator of necrosis/cytotoxicity
(Dobrosi et al., 2008; To´th et al., 2009b).
Of further importance, the growth-inhibitory and cell
death-inducing actions of the TRPV3 activators were mark-
edly abrogated by suppression of [Ca2þ ] of the culturing
medium (from 1.8 to 0.02 mM) or co-application of 10mM
ruthenium red (Figure 4b and c), further arguing for that these
cellular actions are mediated by the opening of the surface
membrane TRPV3 ion channels and the resulted Ca2þ -influx
to the ORS keratinocytes.
However, several lines of evidence suggest that the above
agents may also activate other TRP channels (Xu et al., 2006;
Bı´ro´ et al., 2007). Furthermore, we lack highly selective
and commercially available TRPV3 inhibitors. Therefore,
to further assess and verify the TRPV3 specificity of the
above cellular responses, a series of TRPV3-targeted RNAi
knockdown experiments were carried out in accordance
with the techniques developed in our previous studies and
which were optimized for various cultured human skin cells
(Griger et al., 2007; Dobrosi et al., 2008; To´th et al., 2009b).
(The evaluation of efficacy of the RNAi knockdown is shown
in Supplementary Figure 1 online.) Of greatest importance, in
perfect agreement with the above data, silencing of TRPV3
counteracted the effects of eugenol and 2-APB to suppress
growth (Figure 4d) and to stimulate apoptosis (Figure 4e) of
ORS keratinocytes, which data unambiguously verified the
specific involvement of TRPV3 in mediating the cellular
actions of these agents.
DISCUSSION
Uncovering the as yet ill-characterized functions of various
TRP channels in human skin biology and pathology is an
important, integral part of the ongoing exploration of the
emerging roles of these molecules in regulatory mechanisms
of non-neuronal tissues and cells (Clapham, 2003; Nilius
et al., 2007; Sza´lla´si and Blumberg, 1999; Caterina and
Julius, 2001; Paus et al., 2006a; Bı´ro´ et al., 2007). In this
context, we provide the first evidence that TRPV3, by
suppressing HF keratinocyte proliferation and inducing
apoptosis-driven catagen regression, inhibits in vitro human
hair growth. Given that these effects were generated with
intact components of a normal human mini-organ and under
assay conditions that preserve in vivo-like key functions of
this organ during the test period, our findings are both
physiologically and clinically relevant. Therefore, our current
results, which are perfectly in line with previous data
obtained on various mouse models (Asakawa et al., 2006;
Imura et al., 2007; Xiao et al., 2008; Steinhoff and Bı´ro´, 2009;
Cheng et al., 2010), introduce TRPV3 as a significant player
in human hair growth and cycling control.
That TRPV3 is functionally expressed in well-defined
epithelial cellular compartments of the human HF is
supported by numerous lines of evidence obtained on
primary cultures of ORS keratinocytes. Indeed, plant-derived
and synthetic TRPV3 activators induced membrane currents
and elevations of [Ca2þ ]ic that were effectively abrogated by
the suppression of [Ca2þ ]ec or by the co-administration
of the nonselective TRP channel blocker ruthenium red. Of
further importance, cellular effects of the TRPV3 activators
(i.e., inhibition of proliferation, induction of apoptosis)
were also inhibited by these manipulations and, of greatest
importance, by the RNAi-mediated silencing of TRPV3
expression in these cells. Taken together, these data strongly
argue for that a ‘‘TRPV3 channel opening- Ca2þ influx-
growth arrest and apoptosis of ORS keratinocytes - hair
growth inhibition’’ signaling pathway operates in the
human HF.
Previously, the functional expression of TRPV3 was mostly
identified on (mouse) epidermal keratinocytes. Indeed,
TRPV3-specific heat and pharmacological agent-activated
membrane currents and [Ca2þ ]ic elevations were identified
in these cells (Peier et al., 2002; Cheng et al., 2010; Chung
et al., 2004a, 2004b; Huang et al., 2008; Xiao et al., 2008).
In addition, stimulation of TRPV3 on keratinocytes induced
the release of various mediators (e.g., IL-1a, prostaglandin E2,
ATP; Xu et al., 2006; Huang et al., 2008; Mandadi et al.,
2009), which, as ‘‘intercellular messengers’’, were shown
to activate pain and/or itch sensitive sensory afferents (Huang
et al., 2008; Mandadi et al., 2009). However, these mediators
are recognized proinflammatory agents in the skin (Paus and
Cotsarelis, 1999; Stenn and Paus, 2001; Paus et al., 2006b;
Bı´ro´ et al., 1998b, 2007); hence, TRPV3 channels expressed
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on keratinocytes were suggested to have a role in cutaneous
inflammation. Indeed, transgenic overexpression of a ‘‘gain-
of-function’’ mutant of the TRPV3 gene in epidermal kerati-
nocytes of mice resulted in not only pruritus but also severe
dermatitis (Yoshioka et al., 2009). Furthermore, our pre-
liminary data suggest that activation of TRPV3 significantly
suppresses growth of human epidermal keratinocytes (Bı´ro´
et al., manuscript in preparation). These intriguing findings,
along with our current presentation on the role of TRPV3
in human (and mouse) hair growth control, underscore the
key physiological and pathophysiological significance of
TRPV3, its elusive endogenous ligands, and the coupled
signaling mechanisms in multiple cellular compartments
of the skin.
Of further importance, we and others have identified
almost identical cutaneous regulatory mechanisms with the
central involvement of another TRP channel, i.e., TRPV1.
Indeed, stimulation of TRPV1 was shown to inhibit human
(and murine) hair growth, promote premature catagen
regression of the human HF, suppress proliferation and
induce apoptosis of human epidermal and ORS keratino-
cytes, and induce the release of proinflammatory cytokines
from these cells (Southall et al., 2003; Bodo´ et al., 2005;
Bı´ro´ et al., 2006). It appears, therefore, that TRPV3-coupled
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Figure 4. Activation of transient receptor potential vanilloid-3 (TRPV3) on human outer root sheath (ORS) keratinocytes suppresses proliferation and induces cell
death. (a) ORS keratinocytes were treated with various concentrations of TRPV3 activators for 48 hours medium containing normal (1.8 mM) [Ca2þ ]. Proliferation
was determined by a CyQUANT assay, apoptosis was assessed by a DilC1(5) assay reflecting (decreasing) mitochondrial membrane potential, and necrosis was
determined by a Sytox Green assay. (b,c) The above treatment protocols were performed in low (0.02mM) [Ca2þ ] medium or in the presence of 10mM ruthenium red
(in normal [Ca2þ ] medium), and alterations in proliferation (b) and apoptosis (c) were assessed. (a–c) Data (mean±SEM) are expressed as a percentage of the mean
value (defined as 100 %) of the vehicle-treated control group. * Marks significant (Po0.05) differences compared with the (1.8 mM [Ca2þ ]) vehicle-treated control.
(b,c) # Marks significant (Po0.05) differences compared with the TRPV3 activator-treated group (measured in normal [Ca2þ ] medium). (d,e) Two RNA interference
(RNAi) probes against TRPV3, as well as scrambled RNAi probes, were introduced to ORS keratinocytes. Two days after transfection, cells were treated by TRPV3
activators for 48 hours, and alterations in proliferation (d) and apoptosis (e) were assessed. Data (mean±SEM) are expressed as a percentage of the mean value
(defined as 100%) of the vehicle-treated non-transfected control group. For statistical analysis, * marks significant (Po0.05) differences compared with the scrambled
RNAi-treated group, whereas # marks significant (Po0.05) differences compared with the TRPV3 activator-stimulated scrambled RNAi-treated group. In all cases,
three or four additional experiments yielded similar results. 2-APB, 2-aminoethoxydiphenyl borate.
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signaling mechanisms (similar to those initiated by the
activation of cutaneous TRPV1) act as key regulators of
human hair growth and cycling and, most probably, other
key biological processes of the skin.
In various heterologous systems ectopically expressing
certain TRPs, the TRPV3 activator 2-APB was shown to be
able to activate TRPV1 (Hu et al., 2004; and possibly other
TRP channels as well). However, according to our best
knowledge, there is no data available on the effect of 2-APB
on endogenous TRPV1 expressed by cultured human or
mouse keratinocytes. As (1) various agents may exert
completely different affinities to ‘‘naı¨ve’’ and ‘‘expressed’’
channels; and (2) we have previously shown that the
activation of TRPV1 by capsaicin on human ORS keratino-
cytes induced TRPV1-specific influx of Ca2þ (Bodo´ et al.,
2005), arguing for the functional expression of TRPV1
channels in the surface membrane of the ORS keratinocytes;
our results that TRPV3 small interfering RNA treatment
completely abolished the effects of 2-APB suggest that the
effects of 2-APB to increase [Ca2þ ]ic and induce membrane
current in ORS keratinocytes is most probably mediated by
TRPV3 and not by TRPV1.
Collectively, our findings may also have therapeutic
implications. Our current presentation that stimulation of
TRPV3 in the HF inhibits human hair growth suggests that
(e.g., topically applied) TRPV3 agonists might become
exploitable as new, well-tolerated agents for the clinical
management of unwanted hair growth (hirsutism). Likewise,
future studies are now warranted to explore whether TRPV3
antagonists can be effectively used in the treatment of various
forms of hair loss (effluvium, alopecia). Finally, our data also
invites one to systemically explore in future studies how the
proinflammatory, pruritogenic, and anti-proliferative TRPV3
signaling in the skin can be manipulated in a clinically
desired manner by endogenous and exogenous ligands in the
management of relevant dermatoses such as psoriasis, certain
forms of dermatitis, or even skin tumors. Therefore, clinicians
who apply agents that activate and/or sensitize TRPV3
(e.g., camphor; Peier et al., 2002; Xu et al., 2002) now need
to take the above into account.
MATERIALS AND METHODS
Materials
Eugenol, carvacrol, thymol, and 2-aminoethoxydiphenyl borate
(2-APB) were purchased from Sigma-Aldrich (St Louis, MO).
Isolation and maintenance of HFs
Human skin samples were obtained after obtaining written informed
consent from healthy individuals undergoing dermatosurgery,
adhering to Helsinki guidelines, and after obtaining Institutional
Research Ethics Committee’s permission. Human anagen VI HFs
(n¼ 18–24 per group) were isolated from skin obtained from males
undergoing hair transplantation or females undergoing face-lift
surgery, as we have described before (Telek et al., 2007;
Bodo´ et al., 2005, 2009; Ramot et al., 2010). Isolated HFs
were maintained in Williams’ E medium (Invitrogen, Paisley, UK)
supplemented with 2 mM L-glutamine (Invitrogen), 10 ng ml1
hydrocortisone, 10 mg ml1 insulin, and antibiotics (all from Sigma-
Aldrich). Medium was changed every other day, whereas treat-
ment with various TRPV3 activators was performed daily. Length
measurements were performed on individual HFs using a light
microscope with an eyepiece measuring graticule.
Histology
Cryostat sections (6mm) of cultured HFs were fixed in acetone, air-
dried, and processed for histology. Hematoxylin and eosin
(HE, Sigma-Aldrich) staining was used for studying HF morphology
and hair cycle stage (anagen, catagen) of each HF was assessed
according to defined morphological criteria (Telek et al., 2007; Bodo´
et al., 2005, 2009; Ramot et al., 2010).
ORS keratinocyte cultures
Anagen HFs were digested using trypsin to obtain ORS keratinocytes
(Limat and Noser, 1986; Bodo´ et al., 2005; Ramot et al., 2010).
Similarly, HDFs were obtained from de-epidermized dermis using
enzymatic digestion. ORS cultures were kept on feeder layer of
mitomycin-treated HDFs (Limat et al., 1989; Bodo´ et al., 2005) in a
1:3 mixture of Ham’s F12 and DMEM (both from Invitrogen)
supplemented with 0.1 nM cholera toxin, 5mg ml1 insulin,
0.4 mg ml1 hydrocortisone, 2.43mg ml1 adenine, 2 nM triiodo-
thyronine, 10 ng ml1 epidermal growth factor, 1 mM ascorbyl-
2-phosphate, and antibiotics (all from Sigma-Aldrich).
Immunolabeling of TRPV3
For the detection of TRPV3 on isolated HFs and ORS keratinocytes,
we performed fluorescent immunolabeling (Telek et al., 2007; Bodo´
et al., 2005, 2009; Poeggeler et al., 2010; Ramot et al., 2010).
Cryostat HF sections or acetone-fixed ORS keratinocytes growing on
coverslips were first incubated with primary antibody (1:200,
overnight) against TRPV3 (Abcam, Cambridge, UK) and then with
Alexa Fluor 488 dye-conjugated secondary antibody (Invitrogen)
according to standard procedures. In addition, cultured ORS
keratinocytes were identified by cytokeratin 7 immunolabeling
using a mouse monoclonal anti-cytokeratin 7 antibody (1:100,
Novus Biologicals, Cambridge, UK) and Alexa Fluor 568
dye-conjugated secondary antibody (Invitrogen). Nuclei were
counterstained with Vectashield mounting medium containing
40-6-diamidino-2-phenylindole (Vector Laboratories, Burlingame,
CA). Images were acquired with an Eclipse E600 fluorescent
microscope (Nikon, Tokyo, Japan). As negative controls, the
appropriate primary antibodies were either omitted from the
procedure or were preabsorbed with synthetic blocking peptides.
In addition, the specificity of TRPV3 staining was also measured on
tissues recognized to be positive for the channel; i.e., human
epidermal skin sections (Gopinath et al., 2005; Facer et al., 2007) as
well as normal human epidermal and HaCaT keratinocyte cultures
(Sherkheli et al., 2009; data not shown).
Ki-67/TUNEL double labeling
To evaluate apoptotic cells in the HFs in colocalization with a
proliferation marker Ki-67, a Ki-67/TUNEL double-staining method
was used (Telek et al., 2007; Bodo´ et al., 2005, 2009). Cryostat
sections were fixed in formalin/ethanol/acetic acid and labeled with
a digoxigenin-deoxyUTP (ApopTag Fluorescein In Situ Apoptosis
detection kit; Millipore, Billerica, MA) in presence of terminal
deoxynucleotidyl transferase, followed by incubation with a mouse
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anti-Ki-67 antiserum (DAKO, Carpinteria, CA). TUNELþ cells
were visualized by an anti-digoxigenin FITC-conjugated antibody
(ApopTag kit), whereas Ki-67 was detected by an Alexa Fluor 568
dye-conjugated secondary antibody (Invitrogen). Negative controls
were performed by omitting terminal deoxynucleotidyl transferase
and the Ki-67 antibody. The number of cells positive for Ki-67 and
TUNEL IR was counted per hair bulb and was normalized to the
number of total (40-6-diamidino-2-phenylindoleþ ) cells.
Quantitative real-time PCR
Quantitative real-time PCR was performed on an ABI Prism 7000
sequence detection system (Applied Biosystems, Foster City, CA)
by using the 50 nuclease assay, as we have previously described
(Telek et al., 2007; Bodo´ et al., 2005, 2009; Poeggeler et al., 2010;
Ramot et al., 2010). Total RNA was isolated using TRIzol reagent
(Invitrogen) according to manufacturer’s protocol. A total of 3mg
of total RNA were then reverse transcribed into cDNA by using 15 U
of AMV reverse transcriptase (Promega, Madison, WI) and
0.025mg ml1 random primers (Promega). PCR amplification was
performed by using the TaqMan primers and probes (TRPV3,
assay ID, Hs00376854_m1) using the TaqMan universal PCR master
mix protocol (Applied Biosystem). As internal controlss, transcripts
of glyceraldehyde 3-phosphate dehydrogenase (assay ID Hs999
99905_m1) and cyclophylin (PPIA, assay ID Hs99999904_m1) were
determined.
Western blotting
To determine the expression of TRPV3 in different keratinocyte
cell types, the western blot technique was applied (Bodo´ et al.,
2004, 2005; Telek et al., 2007; Bı´ro´ et al., 1998a, b). Cell lysates
of ORS and HaCaT keratinocytes (the latter cells were used as
positive controls) (Sherkheli et al., 2009) were subjected to
SDS-PAGE, transferred to BioBond nitrocellulose membranes
(Whatman, Maidstone, UK), and then probed with the above
anti-TRPV3 antibody (1:500, Abcam). A horseradish peroxidase
polymer-conjugated anti-rabbit IgG antibody (Envision labeling,
DAKO) was used as a secondary antibody, and the immuno-
reactive bands were visualized by SuperSignal West Pico Chemi-
luminescent Substrate-enhanced chemiluminescence (Pierce,
Rockford, IL) using a Gel Logic 1500 Imaging System (Kodak,
Tokyo, Japan). Negative control was performed by omitting the
primary antibody.
Microfluorimetric measurements of [Ca2þ ]i
ORS keratinocyte cells were seeded in 96-well black-well/clear-
bottom plates (Greiner Bio-One, Kremsmuenster, Austria) at a
density of 20,000 cells per well on mitomycin-treated HDF feeder
cells (900 cells per well) in ORS keratinocyte medium, supplemen-
ted as above, and cultured at 37 1C for 24 h. The cells were then
loaded with the cytoplasmic calcium indicator 2mM Fluo-4 AM
(Invitrogen) at 37 1C for 30 minutes in Hank’s balanced salt solution
(Invitrogen) supplemented with 1% BSA and 2.5 mM probenecid
(both from Sigma-Aldrich). The cells were washed and finally kept in
supplemented Hank’s balanced salt solution for 30 minutes at 37 1C.
The plates were then placed into a FlexStation II384 Fluorescence
Imaging Plate Reader (FLIPR, Molecular Devices, Sunnyvale, CA)
and changes in [Ca2þ ]i (reflected by changes in fluorescence;
lEX¼ 494 nm, lEM¼ 516 nm) induced by various concentrations of
the drugs were recorded in each well (during the measurement, cells
in a given well were exposed to only one given concentration of the
agent). Experiments were performed in quadruplets and the averaged
data (±SEM) were used in the calculations (Marincsa´k et al., 2008;
To´th et al., 2009a).
Patch-clamp experiments
ORS keratinocytes growing on 1 cm diameter coverslips were placed
in a temperature controlled perfusion chamber mounted on a stage
of an inverted Nikon microscope. All experiments were conducted
at 37 1C. Currents were recorded from cells superfused with Tyrode’s
solution containing (in mM) NaCl 140, KCl 5.4, CaCl2 2.5, MgCl2
1.2, HEPES 5, glucose 10, at pH 7.4. 2-APB was added to this
superfusate from a 1 M stock solution in DMSO reaching a final
concentration of 100 mM. Suction pipettes, fabricated from borosili-
cate glass, had tip resistances of 2–4 MW after filling with pipette
solution composed of (in mM) K-aspartate 100, KCl 45, MgCl2 1,
HEPES 5, EGTA 10, K-ATP 3. The pH of this solution was adjusted
to 7.2 with KOH. Membrane currents were recorded with a
Multiclamp-700A intracellular amplifier (Axon Instruments,
Molecular Devices) using the whole-cell configuration of the
patch-clamp technique (Hamill et al., 1981). After establishing
high-resistance (41 GO) seal by gentle suction, the cell membrane
beneath the tip of the electrode was disrupted by further suction
and/or by applying 1.5 V electrical pulses for 1 millisecond. Ion
currents were normalized to cell capacitance, determined in each
cell using short hyperpolarizing pulses from 10 mV to 20 mV.
Average cell capacitance was 34.5±2.5 pF, whereas the series
resistance was typically 5–10 MO and left uncompensated.
Experiments were discarded when the amplitude of the measured
current was unstable within the initial 5 minutes of the experiment,
or the series resistance was high or increased during the measure-
ment. Outputs from the clamp amplifier were digitized at 10 kHz
using an A/D converter (Digidata-1322A, Axon Instruments)
under software control (pClamp 9.0, Axon Instruments; Go¨nczi
et al., 2007).
Determination of cellular proliferation
The degree of cellular growth (reflecting number of viable cells) was
determined by measuring the DNA content of cells using CyQUANT
Cell Proliferation Assay Kit (Invitrogen). ORS keratinocytes (10,000
cells per well) were cultured on mitomycin-treated HDF feeder cells
(900 cells per well) in 96-well black-well/clear-bottom plates
(Greiner Bio-One) in quadruplicates and were treated with various
compounds for the time indicated. Supernatants were then removed
by blotting on paper towels, and the plates were subsequently frozen
at 70 1C. The plates were then thawed at room temperature, and
200ml of CyQUANT dye/cell lysis buffer mixture was added to each
well. After 5 minutes of incubation, fluorescence was measured at
490 nm excitation and 520 nm emission wavelengths using FLIPR
(Molecular Devices; To´th et al., 2009b).
Determination of apoptosis
A decrease in the mitochondrial membrane potential is one of the
earliest markers of apoptosis (Green and Reed, 1998; Susin et al.,
1998). Mitochondrial membrane potential of ORS keratinocytes was
determined using a MitoProbe DiIC1(5) Assay Kit (Invitrogen) using
our previously optimized protocols (Dobrosi et al., 2008; To´th et al.,
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2009b). Cells were cultured and treated as described above. After
removal of supernatants, cells were incubated for 30 minutes with
DilC1(5) working solution and the fluorescence of DilC1(5) was
measured at 630 nm excitation and 670 nm emission wavelengths
using the above FLIPR.
Determination of necrosis
Necrotic cell death was determined by SYTOX Green nucleic acid
staining (Invitrogen). The dye is able to penetrate only to necrotic
cells with ruptured plasma membranes, whereas healthy cells with
intact surface membranes show negligible staining. Cells were
cultured and treated as described above. Supernatants were then
discarded and the cells were incubated with 1mM SYTOX Green
solution. Fluorescence of SYTOX Green was measured at 490 nm
excitation and 520 nm emission wavelengths using a FLIPR (Dobrosi
et al., 2008; To´th et al., 2009b).
RNA interference
ORS keratinocytes were transfected by the Neon Transfection
System (Invitrogen) using the Neon Kit according to manufacturer’s
instructions. Briefly, cells were collected by trypsinization, washed,
and suspended in Resuspension buffer (Invitrogen). Two TRPV3-
specific Stealth RNAi oligonucleotides (IDs: HSS136316 and
HSS175965, 40 nM, Invitrogen) as well as RNAi Negative Control
Duplexes (Scrambled RNAi, Invitrogen) were transfected to the cells
by electroporation (settings: 900 V, 20 milliseconds, two times).
Transfected cells were then plated into 35 mm Petri dishes for
verification and 96-well plates for other assays. The efficacy of small
interfering RNA-driven knockdown (Supplementary Figure 1 online)
was daily evaluated by western blot analysis and Ca-imaging for
4 days, as we have described before (Griger et al., 2007; Dobrosi
et al., 2008; To´th et al., 2009b). In all cases, the specific RNAi
probes resulted in 470% suppression of the expression of TRPV3
by day 2 and remained suppressed for two additional days (data
not shown). Hence, experiments were performed 2 days after
transfection.
Statistical analysis
When applicable, data were analyzed using a two-tailed unpaired
t-test (except for analyzing the patch-clamp data where Student’s
t-test for paired data were applied) and Po0.05 values were
regarded as significant differences.
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